Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
American Journal of Cancer Research|April 12, 2022
FOXO3-dependent suppression of PD-L1 promotes anticancer immune responses via activation of natural killer cellsYoung Min Chung, Wen Bin Tsai, Pragya P Khan, et al.
The Journal of Biological Chemistry|November 8, 2001
Protein phosphatase 4 is involved in tumor necrosis factor-alpha-induced activation of c-Jun N-terminal kinaseGuisheng Zhou, Kathie A Mihindukulasuriya, Rebecca A MacCorkle-Chosnek, et al.
Journal for Immunotherapy of Cancer|December 10, 2021
Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3Young Min Chung, Pragya P Khan, Hong Wang, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2006
Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney diseaseMitsuo Kato, Hang Yuan, Zhong-Gao Xu, et al.
Breast Cancer Research : BCR|March 4, 2008
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesisYiyu Zou, Wen-Bin Tsai, Chien-Jui Cheng, et al.
The Journal of Pathology|January 15, 2023
SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinomaYi-Mei Lee, Yu-Hsin Chen, Da-Liang Ou, et al.
Nature Communications|August 16, 2012
FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damageYoung Min Chung, See-Hyoung Park, Wen-Bin Tsai, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2019
Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinomaZhong-Zhe Lin, Chiun Hsu, Yung-Ming Jeng, et al.
Pageof 3